Skip to main content

Table 4 Comparison of treatment and outcome of patients with KDSS and KD

From: Kawasaki disease shock syndrome: clinical characteristics and possible use of IL-6, IL-10 and IFN-γ as biomarkers for early recognition

Outcome

KDSS (n = 27)

KD (n = 43)

P value

Hospitalized duration (days)

mean ± SD

13.52 ± 5.12

5.35 ± 2.02

< 0.001a

median(range)

12(8-35)

5(3–15)

< 0.001b

CAAs, no(%)

15(55.56)

4(9.30)

< 0.001c

Aseptic meningitis, no. (%)

13(48.15)

2(4.65)

< 0.001 c

Ejection fraction, %,(mean ± SD)

0.61 ± 0.07

0.64 ± 0.05

0.159 c

ECG abnormality,no.(%)

18 (66.67)

2(4.65)

0.001 c

IVIG-resistance,no.(%)

19 (70.37)

1(2.30)

0.001 c

Second dose of IVIG,no(%)

10 (37.04)

2(4.65)

0.002 c

ICU, no.(%)

13 (48.15)

0(0.00)

< 0.001 c

vasopressor,no.(%)

8 (29.63)

0(0.00)

< 0.001 c

Other organ damage,no. (%)

23 (85.19)

6(14.00)

0.001 c

KD recurrence,no. (%)

2(7.41)

1 (2.3)

0.555c

Incomplete KD,no. (%)

8(29.62)

2(4.65)

0.010c

Death, no. (%)

0 (0.00)

0 (0.00)

1.000 c

  1. aTwo-sample t test
  2. bManne-Whitney U test
  3. cFisher’s exact test